Selective GH secretagogue with minimal impact on cortisol, prolactin or appetite.
Ipamorelin is a growth hormone releasing peptide (GHRP) that stimulates GH release with high selectivity — avoiding the cortisol and prolactin elevations seen with older GHRPs like GHRP-6.
Subcutaneous injection 1–3× daily or nightly, often stacked with CJC-1295.
Ghrelin-receptor agonist producing GH release through the pituitary GH-secreting cell.
Very well tolerated. Rare injection-site reactions.
This page is educational and not medical advice. All VitaFlow protocols require evaluation by a licensed Florida physician.
Different pathway — often combined for a fuller effect.
Minimal compared to older GHRPs.
3–6 months.
IGF-1 and metabolic panel.
GHRH analog that stimulates your body's own growth hormone in a physiologic pattern.
Long-acting GHRH analog often paired with Ipamorelin for GH optimization.
FDA-approved GHRH analog with strong evidence for visceral fat reduction.
Meet with a VitaFlow physician to design a protocol tailored to your goals, biomarkers, and lifestyle.
